| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |